Tag: Financing

Pathios Therapeutics Closed US$8.8M Series A and Appointed Stuart Hughes as CEO

Pathios Therapeutics Limited, an innovative biotech company focused on the development of first-in-class therapies for autoimmune diseases and cancer, announced a US$8.8M Series A financing round with...

FDA Awarded $15m to 12 R&D Projects

fda office
After receiving 89 clinical trial grant applications, the US Food and Drug Administration (FDA) selected 12 projects that will be funded with more than $15 million over the next four years. The ann...

Russian Regions Will Receive Additional Funds for Medication Supply

At a meeting of the Government of the Russian Federation on October 2, 2019, it was decided to adopt a draft order “On amendments to the distribution of subventions provided from the federal budget to...

Tenaya Therapeutics Raised $92m to Develop Gene Therapies

gene therapy
The South San Francisco–based start-up Tenaya Therapeutics announced that it raised $92 million in series B financing to take a bold and broad approach to treat cardiac diseases. The start-up is de...

Procarta Announced Award to Progress Pipeline of Antibiotic Precision Meds

Procarta Biosystems, a privately held UK-based biotech company, announced a CARB-X award of up to $9.2 million to progress its pipeline of antibiotic precision medicines. The award includes initial no...

Source Bioscience to Invest €585,000 in Irish Microbiology Labs

The UK-based lab service and product provider will spend $650,000 to improve turnaround times for Irish customers. Source Bioscience has invested €585,000 (US$650,000) in microbiology and sterility...

UK Government Invests over £130 mln to Tackle Serious Diseases

The UK government has announced an investment of over £130 million for new tech to tackle cancer and debilitating illnesses. The news means that thousands of NHS patients could receive faster diagn...

Sanofi Will Pay to Lexicon for Partnership Termination

Lexicon Pharmaceuticals Inc said on Tuesday that France’s Sanofi SA will pay the drugmaker $260 million for the termination of their partnership to develop diabetes drug Zynquista. Shares of Lexico...

Strides to Acquire Majority Stake in Fairmed

Strides Pharma Science Limited has announced its acquisition of majority stake in Fairmed Healthcare AG. Strides Pharma Global Pvt Ltd (SPG) is a step down subsidiary of Strides Pharma Science Limi...

Apexan Pharmaceuticals Got $2.3 mln from NHLBI for Study

Apexan Pharmaceuticals has announced that The National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has awarded a $2.3 million grant to Dr. Reuben Kapur and Dr. M...

ADC Therapeutics to Complete Series E Financing Expansion

ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of antibody drug conjugates (ADCs), announced that it has closed a $76 million expansion of its...

Immuno-Oncology Startup Oncologie Raised $80 million in Venture Financing

biotech-lab
Boston and Shanghai, immuno-oncology startup Oncologie has bagged $80 million in venture financing. The capital will bankroll three clinical-stage programs, licensing deals and the development of the ...

Schrödinger Raised $110m for Expansion of its Drug-Discovery Pipeline

car-t
Schrödinger announced that several new investors have joined its latest funding round, which was completed with a total raise of $110 million to support continued advancement of the company’s industry...

Gilead Sciences Posted Smallest Year-Over-Year Decline of Drugs Sales Since 2015

gilead sciences
Gilead Sciences' hepatitis C treatments appeared stable Thursday as the biotech titan posted its smallest year-over-year decline for the drugs in three years. Meanwhile, Gilead earnings beat first-qua...

Gedeon Richter Underwrites $5mln Convertible Notes of Prima-Temp

Hungarian drugmaker Gedeon Richter said it has underwritten USD 5 million of convertible notes issued by Prima-Temp, a U.S. company that is developing a smart fertility sensor. Richter noted that i...

AbCellera to Initiate Global Health Research

AbCellera announced a two-year agreement with the Bill & Melinda Gates Foundation to help accelerate global health research. The funding, totaling $4.8 M, will support a series of scientific colla...